Journal Title:Journal Of Clinical And Experimental Hepatology
Journal of Clinical and Experimental Hepatology is an academic journal dedicated to clinical and experimental research on liver diseases. Its aim is to provide a platform for liver disease researchers, clinical doctors, and students worldwide to exchange and share the latest research results, in order to promote the prevention, diagnosis, and treatment of liver diseases. This magazine focuses on the combination of clinical and experimental research, which includes in-depth exploration of the pathogenesis of liver diseases and research on clinical diagnosis and treatment practices. The journal focuses on the latest treatment methods for liver diseases, such as drug therapy, surgical treatment, interventional therapy, as well as emerging treatment methods such as gene therapy and stem cell therapy. In addition, the journal also focuses on preventive measures for liver diseases, such as vaccination and health education. The readership mainly includes researchers in the field of liver disease, clinical doctors, and teachers and students from medical schools. By reading this journal, readers can learn about the latest research progress in liver diseases, master advanced diagnostic and treatment techniques, and improve clinical diagnosis and treatment levels. At the same time, the journal also provides a platform for young scholars to showcase their research results, which helps cultivate a new generation of liver disease research talents.
《臨床與實驗肝病學雜志》是一本專注于肝臟疾病臨床和實驗研究的學術期刊,旨在為全球范圍內的肝病研究者、臨床醫生和學生提供一個交流和分享最新研究成果的平臺,以促進肝臟疾病的預防、診斷和治療。該雜志注重臨床與實驗相結合,既有對肝臟疾病發病機制的深入探討,也有針對臨床診療實踐的研究。期刊關注肝臟疾病的最新治療方法,如藥物治療、手術治療、介入治療等,以及新興的治療手段,如基因治療、干細胞治療等。此外,期刊還關注肝臟疾病的預防措施,如疫苗接種、健康教育等。讀者群體主要包括肝病領域的研究者、臨床醫生、醫學院校的師生等。通過閱讀該期刊,讀者可以了解肝臟疾病的最新研究進展,掌握先進的診療技術,提高臨床診療水平。同時,期刊還為年輕學者提供了一個展示自己研究成果的平臺,有助于培養新一代的肝病研究人才。
Journal Of Clinical And Experimental Hepatology由Elsevier出版商出版,收稿方向涵蓋GASTROENTEROLOGY & HEPATOLOGY全領域,平均審稿速度 ,影響因子指數3.3,該期刊近期沒有被列入國際期刊預警名單,廣大學者值得一試。
| 按JIF指標學科分區 | 收錄子集 | 分區 | 排名 | 百分位 |
| 學科:GASTROENTEROLOGY & HEPATOLOGY | ESCI | Q2 | 46 / 143 |
68.2% |
| 按JCI指標學科分區 | 收錄子集 | 分區 | 排名 | 百分位 |
| 學科:GASTROENTEROLOGY & HEPATOLOGY | ESCI | Q2 | 61 / 143 |
57.69% |
名詞解釋:
WOS即Web of Science,是全球獲取學術信息的重要數據庫,Web of Science包括自然科學、社會科學、藝術與人文領域的信息,來自全世界近9,000種最負盛名的高影響力研究期刊及12,000多種學術會議多學科內容。給期刊分區時會按照某一個學科領域劃分,根據這一學科所有按照影響因子數值降序排名,然后平均分成4等份,期刊影響因子值高的就會在高分區中,最后的劃分結果分別是Q1,Q2,Q3,Q4,Q1代表質量最高。
| CiteScore | SJR | SNIP | CiteScore排名 | ||||||||
| 4.9 | 0.787 | 0.772 |
|
名詞解釋:
CiteScore:衡量期刊所發表文獻的平均受引用次數。
SJR:SCImago 期刊等級衡量經過加權后的期刊受引用次數。引用次數的加權值由施引期刊的學科領域和聲望 (SJR) 決定。
SNIP:每篇文章中來源出版物的標準化影響將實際受引用情況對照期刊所屬學科領域中預期的受引用情況進行衡量。
| 是否OA開放訪問: | h-index: | 年文章數: |
| 未開放 | - | 153 |
| Gold OA文章占比: | 2021-2022最新影響因子(數據來源于搜索引擎): | 開源占比(OA被引用占比): |
| 6.87% | 3.3 | |
| 研究類文章占比:文章 ÷(文章 + 綜述) | 期刊收錄: | 中科院《國際期刊預警名單(試行)》名單: |
| 65.36% | SCIE | 否 |
歷年IF值(影響因子):
歷年引文指標和發文量:
歷年自引數據:
若用戶需要出版服務,請聯系出版商。